Skip to main content
. 2014 Jun 6;9(6):e98007. doi: 10.1371/journal.pone.0098007

Table 3. Demographics for Subjects.

Sub ID Age Sex Hand Ethnicity Pain Thresh Level Duration Since Onset of Condition Meds Taken Duration Meds Taken (Years)
*CP01 56 F R C 0.8 0.5 Diovan 0.167
Ovar 2
Marapex 3
Ibuprofen 10
Protonex 10
CP02 65 F A C 0.75 0.5 Vit Sup 0.5
CP03 52 F R C 0.6 5 Cambalta 2
Motrin 2
CP04 61 F R C 1 2 None 0
CP05 55 M L C 1.8 1 Vit Sup 1
CP06 46 F R C 0.3 1 Dilantin 1
Lavoxyl 1
Vit Sup 1
CP07 47 F R C 0.5 2 None 0
CP08 43 M R C 1.2 5 Flexeril 15
Skelaxin 0.67
CP09 46 M R B 1.1 0.5 Sevella 0.083
CP10 52 F R B 0.5 5 Ibuprofen 15
Vit Sup 15
CP11 56 F R C 0.5 5 Percocet 5
Mirapex 5
Trazadone 5
CP12 49 M L C 1 5 None 0
CP13 46 F R B 0.6 0.5 Ibuprofen 8
NC01 39 F R C 1.2
NC02 42 F L C 0.5
NC03 62 M A C 0.4
NC04 50 F R C 0.8
NC05 59 F R C 0.6
NC06 47 M R B 0.8
NC07 46 F R B 0.5
*NC08 51 F R C 0.7
NC09 59 F R C 0.6
NC10 44 F R C 0.9
NC11 38 M L C 0.6
NC12 40 F R C 0.5
NC13 56 M R B 0.5

Sex: F = Female; M = Male. Hand: L = Left; R = Right; a = Ambidextrous. Ethnicity: C = Caucasian; B = Black African American. Pain Thresh Level = Pain Threshold Level of electrical stimulation used in fMRI; Meds = Medication; Vit Sup = Vitamin Supplements.

*Denotes the two individuals misclassified by the Sparse Logistic Regression decoder. All Chronic Pain subjects were diagnosed with muscle-skeletal lower back chronic pain.